Furthermore, naproxen and celecoxib were also shown to reduce PD-1 and LAG3 expression on regulatory T cells, presumably inhibiting the immunosuppressive TME to enhance the anti-tumor efficacy of anti-PD-1/PD-L1 therapy [158]. The gene discussed is CD274; the disease is neoplasm.